2 Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)

3 Genotoxicity of gold nanoparticles in the gilthead seabream (Sparus aurata) after single exposure and combined with the pharmaceutical gemfibrozil

4 Supramolecular pharmaceutical sciences: A novel concept combining pharmaceutical sciences and supramolecular chemistry

5 Generic selection criteria for safety and patient benefit [VIII]: Comparing the physicochemical and pharmaceutical properties of brand-name and generic diclofenac sodium tapes.

6 Possible use of a Nicotiana tabacum ‘Bright Yellow 2’ cell suspension as a model to assess phytotoxicity of pharmaceuticals (diclofenac)

7 Heterogeneous Fenton-like oxidation of pharmaceutical diclofenac by a catalytic iron-oxide ceramic microfiltration membrane

8 Removal of pharmaceuticals by powdered activated carbon adsorption: Effect of particle size and point of addition

9 The initial pharmaceutical development of an artesunate/amodiaquine oral formulation for the treatment of malaria: a public-private partnership

10 Chemical profiling of Centaurea bornmuelleri Hausskn. aerial parts by HPLC-MS/MS and their pharmaceutical effects: From nature to novel perspectives.

11 Extraction and determination of trace amounts of three anticancer pharmaceuticals in urine by three-phase hollow fiber liquid-phase microextraction based on two immiscible organic solvents followed by high-performance liquid chromatography.

12 In Situ Characterization of Pharmaceutical Formulations by Dynamic Nuclear Polarization Enhanced MAS NMR.

13 Study of the state of readiness of pharmaceutical institutions of Ukraine for implementation of integrated quality systems

14 [Practice Examples of Academic Detailing -Prescription Support Based on Basic Pharmaceutical Science and Evidence].

15 Voltammetric Analysis of Cephalexin and Cefazoline in Pharmaceutical Formulation and Biological Samples

16 Curcumin: Biological, Pharmaceutical, Nutraceutical, and Analytical Aspects

17 Development and validation of an ecofriendly chemiluminescence method for the determination of citalopram in pharmaceutical preparations using Cu²+-grafted Oxidized multiwall carbon nanotubes

18 From courts to markets: New evidence on enforcement of pharmaceutical bans in India.

19 Human health risk assessment of pharmaceuticals in treated wastewater reused for non-potable applications in Sharjah, United Arab Emirates.

20 An Exploration of Factors Affecting Deposition of Pharmaceutical Aerosols in the Alberta Idealized Throat.

21 Home treatment and use of informal market of pharmaceutical drugs for the management of paediatric malaria in Cotonou, Benin.

22 Application of the Discrete Element Method for Manufacturing Process Simulation in the Pharmaceutical Industry.

23 Mechanisms of pharmaceutical and personal care product removal in algae-based wastewater treatment systems.

24 A proposal for an alternative approach to particle size method development during early stage small molecule pharmaceutical development.

25 Seasonal and spatial variations of pharmaceuticals and personal care products occurrence and human health risk in drinking water - A case study of China.

26 Concurrence of antibiotic resistant bacteria (ARB), viruses, pharmaceuticals and personal care products (PPCPs) in ambient waters of Guwahati, India: Urban vulnerability and resilience perspective.

27 An evaluation on the intra-day dynamics, seasonal variations and removal of selected pharmaceuticals and personal care products from urban wastewater treatment plants

28 Varying results of early benefit assessment of newly approved pharmaceutical drugs in Germany from 2011 to 2017: A study based on federal joint committee data.

29 The structure of the pharmaceutical market in Iran using concentration indices.

30 Direct UV photolysis of pharmaceutical compounds: Determination of pH-dependent quantum yield and full-scale performance

31 Chitosan: An Update on Potential Biomedical and Pharmaceutical Applications

32 Chitosan Modification and Pharmaceutical/Biomedical Applications

33 Molecular, Cellular and Pharmaceutical Aspects of Biomaterials in Dentistry and Oral and Maxillofacial Surgery. An Internationalization of Higher Education and Research Perspective.

34 Patent implications in the pharmaceutical industry: Are static high prices leading to dynamic innovations?

35 Stone cutting industry waste-supported zinc oxide nanostructures for ultrasonic assisted decomposition of an anti-inflammatory non-steroidal pharmaceutical compound.

36 A novel enzymatic microreactor: Towards transforming the pharmaceutical industry

37 Toxicity of azo dyes in pharmaceutical industry

38 Role of Robotic Process Automation in Pharmaceutical Industries

39 Bioconjugation as a smart immobilization approach for α-amylase enzyme using stimuli-responsive Eudragit-L100 polymer: a robust biocatalyst for applications in pharmaceutical industry

40 Strategy-making process and firm performance in Iranian pharmaceutical industry

41 Evaluation of a Dry Coating Technology as a Substitute for Roller Compaction for Dry Agglomeration Applications in the Pharmaceutical Industry

42 The Contact-Hitting R&D Strategy of Family Firms in the Japanese Pharmaceutical Industry

43 Evaluation of pharmaceutical industry-led access programmes: A standardised framework

44 Microfluidic process intensification for synthesis and formulation in the pharmaceutical industry

45 Knowledge breadth and depth development through successful R&D alliance portfolio configuration: An empirical investigation in the pharmaceutical industry

46 From small molecule generics to biosimilars: Technological upgrading and patterns of distinctive learning processes in the Indian pharmaceutical industry

47 Stock market behavior of pharmaceutical industry in Iran and macroeconomic factors

48 Political connections and strategic choices of emerging market firms: Case study of Russia’s pharmaceutical industry

49 Association between medicine Price declaration by pharmaceutical industries and retail prices in Malaysia's private healthcare sector

50 Determinants of intra-industry trade in pharmaceutical industry products. The case of the Czech republic and its eu trade partners

51 Response of safety pharmacologists to challenges arising from the rapidly evolving changes in the pharmaceutical industry

52 Modeling and Growth Kinetics of Antisolvent Crystallization Applied to the Pharmaceutical Industry

53 Health Technology Assessment in Japan: A Pharmaceutical Industry Perspective

54 Green Chemistry Articles of Interest to the Pharmaceutical Industry

55 Analysis of Pharmaceutical Industry Payments to UK Health Care Organizations in 2015

56 Analysis of energy-related CO <inf>2</inf> emissions in China's pharmaceutical industry and its driving forces

57 A qualitative approach to assess innovation in small infant industries within developing countries: The case of pharmaceuticals in Tunisia<sup>†</sup>

58 Does CSR matter in the pharmaceutical distribution industry?: The balanced scorecard perspective

59 When risks need attention: adoption of green supply chain initiatives in the pharmaceutical industry

60 Issues to consider in the pharmaceutical development of a cardiovascular polypill.

61 Are traditional small-scale screening methods reliable to predict pharmaceutical spray drying?

62 Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK.

63 The removal of pharmaceuticals during wastewater treatment: Can it be predicted accurately?

64 Two Manganese Peroxidases and a Laccase of KU-RNW027 with Novel Properties for Dye and Pharmaceutical Product Degradation in Redox Mediator-Free System.

65 Unveiling of Concealed Processes for the Degradation of Pharmaceutical Compounds by sp.

66 Characterization of recombinant laccase from Trametes versicolor synthesized by Arxula adeninivorans and its application in the degradation of pharmaceuticals

67 In silico Analysis for Laccase-mediated Bioremediation of the Emerging Pharmaceutical Pollutants

68 Bioaccumulation behaviour of pharmaceuticals and personal care products in a constructed wetland.

69 Novel Magnetic Carbon Nanotube-TiO <inf>2</inf> Composites for Solar Light Photocatalytic Degradation of Pharmaceuticals in the Presence of Natural Organic Matter

70 Adsorptive potential of tassel activated carbon towards the removal of metformin hydrochloride from pharmaceutical effluent.

71 Postgraduate Education in Pharmaceutical Medicine in Australia: Evaluation and Evolution to a Global Program Over 20 Years.

72 Adherence of pharmaceutical advertisements in medical journals to FDA guidelines and content for safe prescribing.

73 A review of the effect of pharmaceutical firm drug announcements on stock option pricing.

74 The British Pharmacological Society's WDM Paton Memorial Lecture 2019: How doctors were informed about pharmaceutical products through advertising in the British Medical Journal from 1955/6 to 1985/6.

75 Synergistic catalytic effect between ultrasound waves and pyrimidine-2,4-diamine-functionalized magnetic nanoparticles: Applied for synthesis of 1,4-dihydropyridine pharmaceutical derivatives.

76 Trends in heroin and pharmaceutical-opioid related harms in Victoria, Australia up to 2018.

77 Analysis of pharmaceutical impurities using multi-heartcutting 2D LC coupled with UV-charged aerosol MS detection.

78 Consumer behaviour towards pharmaceutical products: a model development

79 The impact of evidence from clinical trials on counselling for over-the-counter drugs: A national survey of pharmaceutical staff in German pharmacies.

80 A Comparative Study on Different Pharmaceutical Industries and Proposing a Model for the Context of Iran.

81 The impact of pharmaceutical marketing on market access, treatment coverage, pricing, and social welfare

82 Proceed to the innovation in the pharmaceutical industry. The case of Spain

83 Self-Regulation in the Pharmaceutical Industry: The Exposure of Children and Adolescents to Erectile Dysfunction Commercials.

84 First nationwide investigation and environmental risk assessment of 72 pharmaceuticals and personal care products from Sri Lankan surface waterways.

85 Spectrophotometric determination of tranexamic acid in pharmaceutical bulk and dosage forms.

86 Simple spectrofluorimetric methods for determination of veterinary antibiotic drug (apramycin sulfate) in pharmaceutical preparations and milk samples

87 Development of a highly efficient decontamination approach for ceftolozane in the pharmaceutical manufacturing environment.

88 PLANTAGO OVATA: A COMPREHENSIVE REVIEW ON CULTIVATION, BIOCHEMICAL, PHARMACEUTICAL AND PHARMACOLOGICAL ASPECTS.

89 A novel pharmaceutical excipient: Coprecipitation of calcium and magnesium silicate using brine-seawater in date palm cellulose as an absorbing host

90 A novel pharmaceutical excipient: Coprecipitation of calcium and magnesium silicate using brine-seawater in date palm cellulose as an absorbing host

91 Essentials from the pharmaceutical and social laws: Legal requirements on a ban of the mail-order business with drugs

92 Embryonic development, locomotor behavior, biochemical, and epigenetic effects of the pharmaceutical drugs paracetamol and ciprofloxacin in larvae and embryos of Danio rerio when exposed to environmental realistic levels of both drugs.

93 Job satisfaction of executives with reference to information technology and pharmaceutical industries

94 Influence of leadership at top level management in achieving operational excellence in pharmaceuticals

95 Supply Chain Challenges in Pharmaceutical Manufacturing Companies: Using Qualitative System Dynamics Methodology.

96 The Holo-Transcriptome of the Zoantharian Protopalythoa variabilis (Cnidaria: Anthozoa): A Plentiful Source of Enzymes for Potential Application in Green Chemistry, Industrial and Pharmaceutical Biotechnology

97 Public awareness level and occurrence of pharmaceutical residues in drinking water with potential health risk: A study from Kajang (Malaysia).

98 Public awareness level and occurrence of pharmaceutical residues in drinking water with potential health risk: A study from Kajang (Malaysia)

99 Efficient Azacycle Formations Developed in Japanese Pharmaceutical Industries: Elegancy, Logistics, and Training (ELT) "sandwich" for Process Chemists

100 Facets of pharmaceutical microbiology: Between contamination dogma, usefulness and beauty

101 Correction to: Biosynthesis and production of quercitols and their application in the production of pharmaceuticals: current status and prospects (Applied Microbiology and Biotechnology, (2018), 102, 11, (4641-4651), 10.1007/s00253-018-8972-y)

Keyword Connections

Journals

Research Groups

Bibliographies